Australia's approach on drug-supported therapy for post-traumatic stress disorder represents a pivotal shift . Following thorough clinical trials , a pathway for patient use has emerged . Currently, a specialized program, overseen by the nation's Therapeutic Goods Administration, permits psychiatrists to administer copyright to eligible sufferers